The Ross Laboratory for Studies in Neural Birth Defects, Department of Medical Neurobiology, Institute for Medical Research - Israel-Canada, The Hebrew University-Hadassah Medical School, Box 12272, 91120 Jerusalem, Israel.
Neurotoxicol Teratol. 2010 Jul-Aug;32(4):481-8. doi: 10.1016/j.ntt.2010.02.003. Epub 2010 Mar 4.
A fast and simple model which uses lower animals on the evolutionary scale is beneficial for developing procedures for the reversal of neurobehavioral teratogenicity with neural stem cells. Here, we established a procedure for the derivation of chick neural stem cells, establishing embryonic day (E) 10 as optimal for progression to neuronal phenotypes. Cells were obtained from the embryonic cerebral hemispheres and incubated for 5-7 days in enriched medium containing epidermal growth factor (EGF) and basic fibroblast growth factor (FGF2) according to a procedure originally developed for mice. A small percentage of the cells survived, proliferated and formed nestin-positive neurospheres. After removal of the growth factors to allow differentiation (5 days), 74% of the cells differentiated into all major lineages of the nervous system, including neurons (Beta III tubulin-positive, 54% of the total number of differentiated cells), astrocytes (GFAP-positive, 26%), and oligodendrocytes (O4-positive, 20%). These findings demonstrate that the cells were indeed neural stem cells. Next, the cells were transplanted in two allograft chick models; (1) direct cerebral transplantation to 24-h-old chicks, followed by post-transplantation cell tracking at 24 h, 6 days and 14 days, and (2) intravenous transplantation to chick embryos on E13, followed by cell tracking on E19. With both methods, transplanted cells were found in the brain. The chick embryo provides a convenient, precisely-timed and unlimited supply of neural progenitors for therapy by transplantation, as well as constituting a fast and simple model in which to evaluate the ability of neural stem cell transplantation to repair neural damage, steps that are critical for progress toward therapeutic applications.
一个利用进化尺度上较低等动物的快速而简单的模型有利于开发利用神经干细胞逆转神经行为致畸性的程序。在这里,我们建立了一个从小鸡中分离神经干细胞的程序,确定胚胎第 10 天(E10)是向神经元表型分化的最佳时间。从小鸡胚胎大脑半球中获得细胞,并根据最初为小鼠开发的程序,在含有表皮生长因子(EGF)和碱性成纤维细胞生长因子(FGF2)的富集培养基中孵育 5-7 天。一小部分细胞存活、增殖并形成巢蛋白阳性的神经球。去除生长因子以允许分化(5 天)后,74%的细胞分化为神经系统的所有主要谱系,包括神经元(β III 微管蛋白阳性,分化细胞总数的 54%)、星形胶质细胞(GFAP 阳性,26%)和少突胶质细胞(O4 阳性,20%)。这些发现表明这些细胞确实是神经干细胞。接下来,将细胞移植到两种同种异体鸡模型中:(1)直接将细胞移植到 24 小时龄的小鸡大脑中,然后在移植后 24 小时、6 天和 14 天进行细胞追踪,(2)将细胞静脉注射到 E13 期鸡胚中,然后在 E19 期进行细胞追踪。这两种方法都发现移植的细胞存在于大脑中。鸡胚为通过移植进行治疗提供了方便、精确定时和无限供应的神经前体细胞,并且构成了一个快速而简单的模型,可以评估神经干细胞移植修复神经损伤的能力,这是朝着治疗应用迈出的关键步骤。